Differential activation of microglia after experimental spinal cord injury

Journal of Neurotrauma

Volumn 16, Issue 3, 1999, Pages 255-265

  Watanabe, Takako ^a   Yamamoto, Teiji ^a   Abe, Yoshinori ^a   Saito, Naoshi ^a   Kumagai, Tomohiro ^a   Kayama, Hisae ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Complement; CR3; Microglia; OX42; Spinal cord injury

Indexed keywords

COMPLEMENT COMPONENT C3; GLIAL FIBRILLARY ACIDIC PROTEIN; LECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL LOSS; CELL TRANSFORMATION; COMPLEMENT SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROGLIA; NERVE DEGENERATION; NONHUMAN; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SPINAL CORD TRANSSECTION;

EID: 0033042139     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1999.16.255     Document Type: Article

References (36)

1. AIHARA, N., HALL, J.J., PITTS, L.H., FUKUDA, K., and NOBLE, L.J. (1995). Altered immunoexpression of microglia and macrophages after mild head injury. J. Neurotrauma 12, 53-63.
2. BARNUM, S.R. (1995). Complement biosynthesis in the central nervous system. Crit. Rev. Oral. Biol. Med. 6, 132-146.
3. BAUER, J., RUULS, S.R., HUITINGA, I., and DIJKSTRA, C.D. (1996). The role of macrophage subpopulations in autoimmune disease of the central nervous system. Histochem. J. 28, 83-97.
4. BELLER, D.I., SPRINGER, T.A., and SCHREIBER, R.D. (1982). Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156, 1000-1009.
5. BENVENISTE, E.N. (1992). Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am. J. Physiol. 263, C1-C16.
6. BUTTINI, M., APPEL, K., SAUTER, A., GEBICKE-HAERTER, P.-J., and BODDEKE, H.W.G.M. (1996). Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71, 1-16.
7. CUZNER, M.L., LOUGHLIN, A.J., MOSLEY, K., and WOODROOFE, M.N. (1994). The role of microglia macrophages in the processes of inflammatory demyelination and remyelination. Neuropathol. Appl. Neurobiol. 20, 200-201.
8. DUSART, I., and SCHWAB, M.E. (1994). Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6, 712-724.
9. ENG, L.F., GHIRNIKAR, R.S., and LEE, Y.L. (1996). Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem. Res. 21, 511-525.
10. FEARON, D.T., and WONG, W.W. (1983). Complement ligand-receptor interactions that mediate biological responses. Ann. Rev. Immunol. 1, 243-271.
11. GASQUE, P., FONTAINE, M., and MORGAN, B.P. (1995). Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154, 4726-4733.
12. GEHRMANN, J., BANATI, R.B., WIESSNER, C., HOSSMANN, K.A., and KREUTZBERG, G.W. (1995). Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol. Appl. Neurobiol. 21, 277-289.
13. GENDELMAN, H.E., and TARDIEU, M. (1994). Macrophages/microglia and the pathophysiology of CNS injuries in AIDS. J. Leukocyte Biol. 56, 387-388.
14. GEORGE, R., and GRIFFIN, J.W. (1994). Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp. Neurol. 129, 225-236.
15. GIORDANA, M.T., ATTANASIO, A., CAVALLA, P., MIGHELI, A., VIGLIANI, M.C., and SCHIFFER, D. (1994). Reactive cell proliferation and microglia following injury to the rat brain. Neuropathol. Appl. Neurobiol. 20, 163-174.
16. IIZUKA, H., YAMAMOTO, H., IWASAKI, Y., YAMAMOTO, T., and KONNO, H. (1987). Evolution of tissue damage in compressive spinal cord injury in rats. J. Neurosurg. 66, 595-603.
17. KONNO, H., YAMAMOTO, T., IWASAKI, Y., SAITOH, T., SUZUKI, H., and TERUNUMA, H. (1989). Ia-expressing microglial cells in experimental allergic encephalomyelitis in rats. Acta Neuropathol. 77, 472-479.
18. KONNO, H., YAMAMOTO, T., IWASAKI, Y., SUZUKI, H., SAITO, T., and TERUNUMA, H. (1989). Wallerian degeneration induces Ia-antigen expression in the rat brain. J. Neuroimmunol. 25, 151-159.
19. KOSHINAGA, M., and WHITTEMORE, S.R. (1995). The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J. Neurotrauma 12, 209-222.
20. KOSKI, C.L., VANGURI, P., and SHIN, M.L. (1985). Activation of the alternative pathway of complement by human peripheral nerve myelin. J. Immunol. 134, 1810-1814.
21. KREUTZBERG, G.W. (1996). Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
22. LIU, L., TÖRNQVIST, E., MATTSSON, P., et al. (1995). Complement and clustering in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat. Neurosciences 68, 167-179.
23. LOTAN, M., and SCHWARTZ, M. (1994). Cross talk between the immune system and the nervous system in response to injury: implications for regeneration. F.A.S.E.B. J. 8, 1026-1033.
24. LUE, L.F., BRACHOVA, L., CIVIN, W.H., and ROGERS, J. (1996). Inflammation, a β deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropathol. Exp. Neurol. 55, 1083-1088.
25. PERRY, V.H., ANDERSSON, P.-B., and GORDON, S. (1993). Macrophages and inflammation in the central nervous system. Trends Neurosci. 16, 268-273.
26. POPOVICH, P.G., WEI, P., and STOKES, B.T. (1997). Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377, 443-464.
27. RABB, H., MICHISHITA, M., SHARMA, C.P., BROWN, D., and ARNAOUT, M.A. (1993). Cytoplasmic tails of human complement receptor type 3 (CR3, CD11b/CD18) regulate ligand avidity and the internalization of occupied receptors. J. Immunol. 151, 990-1002.
28. REID, D.M., PERRY, V.H., ANDERSSON, P.B., and GORDON, S. (1993). Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier. Neuroscience 56, 529-533.
29. ROBINSON, A.P., WHITE, T.M., and MASON, DW. (1986). Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 57, 239-247.
30. SCOLDING, N.J., ZAJICEK, J.P., WOOD, N., and COMPSTON, D.A.S. (1994). The pathogenesis of demyelinating disease. Prog. Neurobiol. 43, 143-173.
31. SHIMOJI, S., WATANABE, T., KAYAMA, H., and YAMAMOTO, T. (1995). Mechanism of microglial activation as studied by retrogradely transported neurotoxin-induced motor neuron degeneration. Adv. Neurotrauma Res. 7, 105-111.
32. STICHEL, C.C., and MÜLLER, H.-W. (1994). Extensive and long-lasting changes of glial cells following transection of the postcommissural fornix in the adult rat. Glia 10, 89-100.
33. STREIT, W.J., and KINCAID-COLTON, C.A. (1995). The brain's immune system. Sci. Am. 273, 38-43.
34. TOWFIGHI, J., ZEC, N., YAGER, J., HOUSMAN, C., and VANNUCCI, R.C. (1995). Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: a light microscopic study. Acta Neuropathol. 90, 375-386.
35. VANGURI, P., KOSKI, C.L., SILVERMAN, B., and SHIN, M.L. (1982). Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. Proc. Natl. Acad. Sci. U.S.A. 79, 3290-3294.
36. VANGURI, P., and SHIN, M.L. (1986). Activation of complement by myelin: identification of C1-binding proteins of human myelin from central nervous tissue. J. Neurochem. 46, 1535-1541.